Status:
COMPLETED
Immunotherapy & Me
Lead Sponsor:
Cancer Support Community, Research and Training Institute, Philadelphia
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Immunotherapy \& Me is a pilot study to determine patient and provider needs around immunotherapy treatment, and to determine the most meaningful resources to improve patient outcomes and decrease cos...
Detailed Description
As usage and indications for immunotherapy increase, there presents a critical need to identify patient-centered and practice solutions across the continuum of care. Immunotherapy \& Me is an innovati...
Eligibility Criteria
Inclusion
- Receiving immunotherapy as a cancer treatment at a participating pilot site location
- English- or Spanish-speaking, or having access to a translator
Exclusion
- \-
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT03347058
Start Date
December 1 2017
End Date
March 31 2021
Last Update
February 8 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic Health Initiatives
Englewood, Colorado, United States, 80112
2
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States, 14263
3
OHC
Cincinnati, Ohio, United States, 45242
4
Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States, 17325